NCCN Unveils Evidence Blocks for CML and Multiple Myeloma
New visual tool illustrates five dimensions of value within NCCN Guidelines
SAN FRANCISCO, Calif., (October 16, 2105) - The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers, today unveiled its new value initiative-the NCCN Evidence Blocks™, published within new versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Chronic Myelogenous Leukemia (CML) and Multiple Myeloma.
'I...
Source: National Comprehensive Cancer Network - Category: Cancer & Oncology Source Type: news
More News: Cancer | Cancer & Oncology | Chronic Leukemia | Chronic Myeloid Leukaemia | Leukemia | Myeloma